Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Liabilities Trends
- The company’s current liabilities exhibited considerable volatility, starting at approximately $2.1 billion and peaking above $3.9 billion by the end of the observed period. Key components such as accounts payable and accrued expenses and other current liabilities each showed fluctuations, with accounts payable high variability, reaching almost $900 million at its peak, while accrued expenses rose broadly toward $3 billion over the timeline.
- Long-term debt displayed a growing and steady trend, with values rising incrementally from about $1.98 billion to nearly $1.99 billion. The recorded finance lease liabilities, including both current and noncurrent portions, remained relatively stable with the noncurrent portion consistently around $720 million and the current portion appearing only intermittently.
- Deferred revenue demonstrated fluctuations without a clear directional trend, occurring in both current and noncurrent categories and ranging roughly between $27 million and $628 million, reflecting varying customer advance payments or obligations.
- Other noncurrent liabilities and total noncurrent liabilities showed a marked upward trend, with other noncurrent liabilities rising from approximately $772 million to about $1.86 billion, and total noncurrent liabilities reaching over $4.7 billion by the end, indicating increasing long-term financial obligations.
- Total liabilities gradually increased overall, from about $3.6 billion to about $9.2 billion, with some periods of slower growth or minor decreases, signaling expansion in the company's total obligations over the analyzed quarters.
- Equity Trends
- Common stock value held constant throughout the period, indicating no share issuance impacting par value. Other equity measures showed significant growth:
- Additional paid-in capital increased steadily from approximately $5.2 billion to nearly $13.8 billion, suggesting continued infusion of capital or equity-related transactions.
- Retained earnings experienced robust growth, rising from around $8 billion to over $35 billion, reflecting cumulative profitable operations and accumulation of net income.
- Treasury stock at cost expanded substantially from roughly $1 billion to about $17.9 billion in negative value, representing increased repurchase or retirement of company shares.
- Accumulated other comprehensive income/loss exhibited oscillations between gains and losses, with values varying from negative $275 million to positive nearly $70 million, indicating fluctuations in unrealized gains or losses from certain investments and foreign currency translations.
- Overall stockholders’ equity demonstrated a generally upward trajectory, growing from approximately $12.1 billion to over $30.9 billion, despite some intermediate decreases, reflecting strengthened financial position and net asset accumulation.
- Summary of Financial Position
- The combined total of liabilities and stockholders’ equity showed steady growth from roughly $15.8 billion to $40.2 billion. This indicates an expansion in the company’s overall balance sheet size throughout the period, primarily driven by increases in both liabilities (notably long-term and current liabilities) and equity (additional paid-in capital and retained earnings).
- The observed patterns point to active capital management, including equity capital inflows and share repurchases, alongside increased liabilities possibly associated with growth initiatives or financing activities.
- Fluctuations in current liabilities and deferred revenue indicate evolving operational dynamics, while the steady rise in long-term debt and noncurrent liabilities suggest an emphasis on long-term financing structure.
- Despite the growth in liabilities, the company’s equity base expanded considerably, underpinning a sound net asset position.